Improving Lung Cancer Clinical Trial Design: Tech Can Help, but Relationships Are Key

Speakers at the 2024 World Conference on Lung Cancer highlighted the use of new technologies and emerging end points in clinical trials, emphasizing the importance of relationships with investigators, patients, and families. They discussed the evolving role of end points like event-free survival and pathologic complete response, and the need for advanced technology in standardizing trial design. Successful trial design requires pragmatic and adaptive protocols, and strong relationships are crucial for patient participation and trial success.